000 01277 a2200373 4500
005 20250513110353.0
264 0 _c19970429
008 199704s 0 0 eng d
022 _a0301-0147
024 7 _a10.1159/000217293
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSandset, P M
245 0 0 _aTissue factor pathway inhibitor (TFPI)--an update.
_h[electronic resource]
260 _bHaemostasis
_cOct 1996
300 _a154-65 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntithrombins
_xpharmacology
650 0 4 _aBlood Coagulation
_xdrug effects
650 0 4 _aEndothelium, Vascular
_xmetabolism
650 0 4 _aFactor VIIa
_xmetabolism
650 0 4 _aFactor Xa Inhibitors
650 0 4 _aHemophilia A
_xdrug therapy
650 0 4 _aHeparin
_xpharmacology
650 0 4 _aHumans
650 0 4 _aLipoproteins
_xchemistry
650 0 4 _aLipoproteins, LDL
_xmetabolism
650 0 4 _aProtein Binding
650 0 4 _aProtein Structure, Tertiary
650 0 4 _aRecombinant Fusion Proteins
_xtherapeutic use
650 0 4 _aRecombinant Proteins
_xtherapeutic use
773 0 _tHaemostasis
_gvol. 26 Suppl 4
_gp. 154-65
856 4 0 _uhttps://doi.org/10.1159/000217293
_zAvailable from publisher's website
999 _c8970722
_d8970722